Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate Efficacy and Safety of 0.65 g and 1.3 g Oral Doses of XP12B-MR TID During Menstruation for the Treatment of Menorrhagia

Description: Incorporates Protocol Amendment 1. XP12B-MR-301 National multisite clinical trial of new medication for treating menorrhagia in women without bleeding disorders
IRB Number: N/A
Status: Not Enrolling; Study complete
Principal Name: Patricia Newcomb, MD
Contact Name: Patricia Newcomb, MD
Phone: (585) 922-3640
Alternative Phone: Email: patricia.newcomb@rochestergeneral.org